MYOS Corp. Encourages Partnering with Pets for Muscle Health and Longevity
January 08, 2025 10:23 ET
|
MYOS PET
Fortetropin, a patented, natural bioactive compound found in all MYOS muscle supplements is clinically shown to support muscle health in dogs and cats.
iHerb Debuts Digital Wellness Hub to Empower Personal Health Goals
January 02, 2025 14:19 ET
|
iHerb Holdings, Inc.
The Hub provides valuable insights on the role vitamins, minerals, and supplements, herbs and natural remedies play in promoting a healthy lifestyle.
Investissements Purpose publie son rapport annuel de 2024 et l’examen actuariel de sa caisse de retraite Longévité
November 28, 2024 10:20 ET
|
Investissements Purpose
TORONTO, 28 nov. 2024 (GLOBE NEWSWIRE) -- Investissements Purpose Inc. (« Purpose ») a le plaisir de publier le troisième rapport annuel de Fonds de pension Longévité (« Longévité » ou « le...
Purpose Investments Releases 2024 Annual Report with Actuarial Review for Its Longevity Pension Fund
November 28, 2024 10:20 ET
|
Purpose Investments Inc.
TORONTO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”) is pleased to release the third annual report for its Longevity Pension Fund (“Longevity” or “the Fund”), the world’s...
UPDATE - Canada’s First Precision Health and Longevity Summit 2024: Uniting Global Leaders on November 15-16
November 13, 2024 16:34 ET
|
BioAro
Canada's first Precision Health and Longevity Summit 2024 gathers world leaders in Calgary to pioneer strategies in personalized health, AI, and longevity.
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 04, 2024 07:30 ET
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
Biongevity Enhances Longevity Strategy with Harish Consul as Chief Venture Capital Advisor
September 04, 2024 09:49 ET
|
BioAro
Biongevity appoints Harish Consul as Chief Venture Capital Advisor, accelerating global growth with innovative precision health and longevity strategies.
Unlocking the Secrets of Immortality: KCSA Podcast Labs Dives into $43 Billion Longevity Industry
September 03, 2024 15:00 ET
|
KCSA Strategic Communications
New York, Sept. 03, 2024 (GLOBE NEWSWIRE) -- NEW YORK, September 3, 2024 - In a world where billionaires are racing to extend human lifespan, KCSA Strategic Communications is pulling back the...
PanOmiQ Set’s New Benchmark with 100% Accuracy in Whole Genome Sequencing Testing
August 20, 2024 09:48 ET
|
BioAro
BioAro's PanOmiQ achieves 100% accuracy in Whole Genome Sequencing, setting a new benchmark; a 15-day free trial of AI-powered software is now available.
Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity
August 13, 2024 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy aging, is excited to...